
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. (ACRS)
WebsitePrice
Market cap
Next catalystExpected Q1 2027ATI-052 — planned Phase 2b EoE trial · Trial initiationCompany release ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved